Milestone Scientific Inc. MLSS NYSE

Milestone Scientific Inc. (MLSS) reported total assets of $7.81M and total liabilities of $4.99M for fiscal year 2025, resulting in total equity of $2.81M.

The company held $1.11M in cash and short-term investments. Total debt stood at $1.02M, with net debt of $-92.4K. The Debt-to-Equity (D/E) ratio was 0.36 (conservative).

Current ratio is 1.81, indicating strong short-term liquidity. Interest coverage is -222.5x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (50/100) — Total assets $7.81M and equity $2.81M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.36 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 56/100 with 3/7 criteria passed.

INFU

InfuSystem Holdings, Inc.

$10.20

+2.13%

OCX

OncoCyte Corporation

$3.20

+17.22%

NTRB

Nutriband Inc.

$4.08

+0.49%

MIRA

MIRA Pharmaceuticals, Inc.

$1.03

-1.90%

SABS

SAB Biotherapeutics, Inc.

$4.05

+4.92%

POCI

Precision Optics Corporation, Inc.

$4.48

+3.94%

IGC

IGC Pharma, Inc.

$0.32

+3.19%

MYO

Myomo, Inc.

$0.80

+1.01%